Peter J Wilkinson Insider Trading $PPDI PHARMACEUTICAL PRODUCT DEVELOPMENT INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter J Wilkinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter J Wilkinson. Peter J Wilkinson is SVP, Chief Accounting Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and VP of Fin./Chief Acctg. Off. in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI).
Peter J Wilkinson in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Trading Symbol: PPDIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Peter J Wilkinson: VP of Fin./Chief Acctg. Off.
Holdings: 474 shares
Latest Transaction: Oct 03 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter J Wilkinson in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 39.01 | 4,000 | 156,040 | 4,000 | |
Jul 08 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 36.33 | 241 | 8,756 | 474 | 233 to 474 (+103.43 %) |
Feb 22 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 44.78 | 6,065 | 271,591 | 6,065 | |
Jan 04 2008 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 34.44 | 233 | 8,025 | 233 | 0 to 233 |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | M | 13.00 | 6,000 | 78,000 | 0 | |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.08 | 76 | 3,198 | 0 | 76 to 0 (-100.00 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.07 | 100 | 4,207 | 76 | 176 to 76 (-56.82 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.06 | 1,100 | 46,266 | 176 | 1.3 K to 176 (-86.21 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.04 | 100 | 4,204 | 1,276 | 1.4 K to 1.3 K (-7.27 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.02 | 100 | 4,202 | 1,376 | 1.5 K to 1.4 K (-6.78 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.01 | 1,455 | 61,125 | 1,476 | 2.9 K to 1.5 K (-49.64 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 42.05 | 3,069 | 129,051 | 2,931 | 6 K to 2.9 K (-51.15 %) |
Nov 28 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | M | 13.00 | 6,000 | 78,000 | 6,000 | 0 to 6 K |
Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.79 | 318 | 11,699 | 0 | 318 to 0 (-100.00 %) |
Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.74 | 395 | 14,512 | 318 | 713 to 318 (-55.40 %) |
Aug 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Sell | S | 36.73 | 574 | 21,083 | 713 | 1.3 K to 713 (-44.60 %) |
Jul 05 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Buy | I | 29.00 | 199 | 5,771 | 1,286 | 1.1 K to 1.3 K (+18.31 %) |
May 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 33.82 | 15,000 | 507,300 | 15,000 |
Page: 1